Quanterix (QTRX) late Monday reported a Q4 net loss of $0.30 per diluted share, wider than a $0.23 loss a year earlier.
One analyst polled by FactSet expected a $0.26 loss.
Revenue for the quarter ended Dec. 31 was $35.2 million, compared with $31.5 million a year earlier.
Analysts expected $34.5 million.
For 2025, the medical device company is expecting between $140.0 million to $146.0 million in revenue.
Analysts are looking for $155.1 million.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。